INSECTICID614.00

Insecticides (India) Limited

· Chemicals
₹ CrorePeersIPLMOLBHARATRASPUNJABCHEMASTECGSPCROPDHARMAJBHAGCHEMMcap ₹1,787 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation29.329.235.5
+ Finance Costs10.96.916.9
+ Interest Income-0.5-2.4-0.3
+ Dividend Income-0.2-0.2-0.3
+ Other — Cash Effects are Investing / Financing0.07.6-1.8
+ Other Reconciling Items-0.10.00.0
Changes in Working Capital
+ Inventories54.8-78.9106.0
+ Trade Receivables — Current-2.5-94.0-101.3
+ Trade Receivables — Non-current0.0-0.1-0.0
+ Other Financial Assets — Current-1.7-7.1-5.2
+ Other Financial Assets — Non-current-0.4-0.3-0.5
+ Other Current Assets-27.04.03.3
+ Trade Payables — Current-28.091.1-74.8
+ Other Financial Liabilities — Current4.8-3.04.3
+ Other Current Liabilities24.1-12.3-7.7
+ Provisions — Current0.02.6-4.3
+ Provisions — Non-current1.90.00.0
Cash from Operating Activities
Profit Before Tax (per I/S)131.9192.2186.4167.7
+ Total Adjustments (incl. Working Capital)65.3-56.9-30.0
Cash from Operations (pre-tax)197.2135.3156.3
+ Income Taxes Paid13.541.856.1
Cash from Operating Activities183.793.5100.2
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)49.037.394.6
+ Disp of Fixed Assets5.42.62.0
+ Acq of Investment Property0.08.00.0
+ Disp of Investment Property0.02.45.6
+ Acq of Other Long-term Assets0.0-0.00.1
+ Disp of Other Long-term Assets-0.10.00.0
+ Dividends Received — Investing0.20.20.3
+ Interest Received — Investing0.52.40.3
Cash from Investing Activities-43.0-37.7-86.5
Cash from Financing Activities
+ Buyback / Redemption of Own Shares0.061.90.0
+ Proceeds from Borrowings-58.529.256.2
+ Repayment of Borrowings17.913.313.3
+ Payment of Lease Liabilities1.82.22.8
+ Interest Paid11.07.016.8
+ Dividends Paid8.95.95.8
Cash from Financing Activities-98.1-61.117.5
Net Changes in Cash (pre-FX)42.6-5.431.3
Net Changes in Cash42.6-5.431.3
Closing Cash61.2
Reference Items
EBITDA162.6221.2227.0210.1
EBITDA Margin %8.2711.0610.6110.20
Free Cash Flow (CFO − Capex)134.756.25.75.7
Free Cash Flow to Equity65.633.5
Free Cash Flow per Basic Share46.2819.301.941.94
Price to Free Cash Flow315.95
Cash Flow to Net Income1.790.660.72
Cash Paid for Taxes13.541.856.1
Cash Paid for Interest11.07.016.8
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.